Go Pro
→ Your $29.97 book is free today (From Profits Run) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Hyperfine, Inc. stock logo
HYPR
Hyperfine
$0.87
+7.9%		$0.86
$0.75
▼
$2.22
$85.69M1.45408,197 shs1.03 million shs
Pulmonx Corporation stock logo
LUNG
Pulmonx
$1.91
$2.04
$1.13
▼
$2.89
$82.03M0.33264,551 shs166,793 shs
NeurAxis, Inc. stock logo
NRXS
NeurAxis
$7.17
-2.7%		$6.52
$2.21
▼
$9.33
$90.04M1.47134,854 shs134,873 shs
Inspira Technologies OXY B.H.N. Ltd stock logo
QTEX
Inspira Technologies OXY B.H.N.
$0.78
+15.0%		$0.88
$0.28
▼
$3.85
$24.52M4.231.70 million shs11.94 million shs
7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Hyperfine, Inc. stock logo
HYPR
Hyperfine
+0.37%+2.28%-1.98%-37.85%-44.28%
Pulmonx Corporation stock logo
LUNG
Pulmonx
-3.54%-4.50%-19.75%+37.41%+17.90%
NeurAxis, Inc. stock logo
NRXS
NeurAxis
-5.03%+0.82%+22.63%+4.39%+139.29%
Inspira Technologies OXY B.H.N. Ltd stock logo
QTEX
Inspira Technologies OXY B.H.N.
+0.06%-11.43%-17.56%-52.31%+68,199,900.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Hyperfine, Inc. stock logo
HYPR
Hyperfine
$0.87
+7.9%		$0.86
$0.75
▼
$2.22
$85.69M1.45408,197 shs1.03 million shs
Pulmonx Corporation stock logo
LUNG
Pulmonx
$1.91
$2.04
$1.13
▼
$2.89
$82.03M0.33264,551 shs166,793 shs
NeurAxis, Inc. stock logo
NRXS
NeurAxis
$7.17
-2.7%		$6.52
$2.21
▼
$9.33
$90.04M1.47134,854 shs134,873 shs
Inspira Technologies OXY B.H.N. Ltd stock logo
QTEX
Inspira Technologies OXY B.H.N.
$0.78
+15.0%		$0.88
$0.28
▼
$3.85
$24.52M4.231.70 million shs11.94 million shs
7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Hyperfine, Inc. stock logo
HYPR
Hyperfine
+0.37%+2.28%-1.98%-37.85%-44.28%
Pulmonx Corporation stock logo
LUNG
Pulmonx
-3.54%-4.50%-19.75%+37.41%+17.90%
NeurAxis, Inc. stock logo
NRXS
NeurAxis
-5.03%+0.82%+22.63%+4.39%+139.29%
Inspira Technologies OXY B.H.N. Ltd stock logo
QTEX
Inspira Technologies OXY B.H.N.
+0.06%-11.43%-17.56%-52.31%+68,199,900.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Hyperfine, Inc. stock logo
HYPR
Hyperfine
2.40
Hold$2.03133.26% Upside
Pulmonx Corporation stock logo
LUNG
Pulmonx
2.50
Moderate Buy$7.67301.40% Upside
NeurAxis, Inc. stock logo
NRXS
NeurAxis
3.00
Buy$13.0081.31% Upside
Inspira Technologies OXY B.H.N. Ltd stock logo
QTEX
Inspira Technologies OXY B.H.N.
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest QTEX, NRXS, HYPR, and LUNG Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/25/2026
Inspira Technologies OXY B.H.N. Ltd stock logo
QTEX
Inspira Technologies OXY B.H.N.
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
9/22/2026
Hyperfine, Inc. stock logo
HYPR
Hyperfine
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$2.00
9/14/2026
Hyperfine, Inc. stock logo
HYPR
Hyperfine
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$2.00
8/25/2026
Pulmonx Corporation stock logo
LUNG
Pulmonx
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
8/24/2026
Inspira Technologies OXY B.H.N. Ltd stock logo
QTEX
Inspira Technologies OXY B.H.N.
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
8/20/2026
Hyperfine, Inc. stock logo
HYPR
Hyperfine
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$2.00
8/10/2026
Hyperfine, Inc. stock logo
HYPR
Hyperfine
B. Riley Financial, Inc. logo
B. Riley Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$2.00 ➝ $1.60
7/17/2026
Hyperfine, Inc. stock logo
HYPR
Hyperfine
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
7/13/2026
Pulmonx Corporation stock logo
LUNG
Pulmonx
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
(Data available from 10/1/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Hyperfine, Inc. stock logo
HYPR
Hyperfine
$11.40M8.11N/AN/A$0.42 per share2.08
Pulmonx Corporation stock logo
LUNG
Pulmonx
$90.50M0.91N/AN/A$1.31 per share1.46
NeurAxis, Inc. stock logo
NRXS
NeurAxis
$5.32M16.94N/AN/A($0.27) per share-26.56
Inspira Technologies OXY B.H.N. Ltd stock logo
QTEX
Inspira Technologies OXY B.H.N.
$290K97.26N/AN/A$0.06 per share13.08
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Hyperfine, Inc. stock logo
HYPR
Hyperfine
-$35.57M-$0.38N/AN/AN/A-210.75%-97.88%-61.81%11/12/2026 (Estimated)
Pulmonx Corporation stock logo
LUNG
Pulmonx
-$54M-$1.16N/AN/AN/A-55.03%-96.66%-38.32%11/11/2026 (Estimated)
NeurAxis, Inc. stock logo
NRXS
NeurAxis
-$14.63M-$0.78N/AN/AN/A-492.76%N/A-641.25%11/17/2026 (Estimated)
Inspira Technologies OXY B.H.N. Ltd stock logo
QTEX
Inspira Technologies OXY B.H.N.
-$13.22MN/AN/AN/AN/AN/AN/AN/AN/A

Latest QTEX, NRXS, HYPR, and LUNG Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
9/24/2026Q2 2026
Inspira Technologies OXY B.H.N. Ltd stock logo
QTEX
Inspira Technologies OXY B.H.N.
N/A-$0.07N/A-$0.07N/A$0.78 million
8/6/2026Q2 2026
Hyperfine, Inc. stock logo
HYPR
Hyperfine
-$0.09-$0.09N/A-$0.09$4.14 million$3.90 million
7/29/2026Q2 2026
Pulmonx Corporation stock logo
LUNG
Pulmonx
-$0.28-$0.24+$0.04-$0.24$22.39 million$22.76 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Hyperfine, Inc. stock logo
HYPR
Hyperfine
N/AN/AN/AN/AN/A
Pulmonx Corporation stock logo
LUNG
Pulmonx
N/AN/AN/AN/AN/A
NeurAxis, Inc. stock logo
NRXS
NeurAxis
N/AN/AN/AN/AN/A
Inspira Technologies OXY B.H.N. Ltd stock logo
QTEX
Inspira Technologies OXY B.H.N.
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Hyperfine, Inc. stock logo
HYPR
Hyperfine
0.36
6.15
5.45
Pulmonx Corporation stock logo
LUNG
Pulmonx
0.95
4.32
3.52
NeurAxis, Inc. stock logo
NRXS
NeurAxis
N/A
0.24
0.23
Inspira Technologies OXY B.H.N. Ltd stock logo
QTEX
Inspira Technologies OXY B.H.N.
0.12
2.00
1.62

Institutional Ownership

CompanyInstitutional Ownership
Hyperfine, Inc. stock logo
HYPR
Hyperfine
15.03%
Pulmonx Corporation stock logo
LUNG
Pulmonx
91.04%
NeurAxis, Inc. stock logo
NRXS
NeurAxis
11.77%
Inspira Technologies OXY B.H.N. Ltd stock logo
QTEX
Inspira Technologies OXY B.H.N.
12.72%

Insider Ownership

CompanyInsider Ownership
Hyperfine, Inc. stock logo
HYPR
Hyperfine
26.33%
Pulmonx Corporation stock logo
LUNG
Pulmonx
7.50%
NeurAxis, Inc. stock logo
NRXS
NeurAxis
21.10%
Inspira Technologies OXY B.H.N. Ltd stock logo
QTEX
Inspira Technologies OXY B.H.N.
29.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Hyperfine, Inc. stock logo
HYPR
Hyperfine
102106.05 million78.13 millionOptionable
Pulmonx Corporation stock logo
LUNG
Pulmonx
29642.95 million39.73 millionOptionable
NeurAxis, Inc. stock logo
NRXS
NeurAxis
2412.56 million6.09 millionNot Optionable
Inspira Technologies OXY B.H.N. Ltd stock logo
QTEX
Inspira Technologies OXY B.H.N.
4135.95 million25.38 millionN/A

Recent News About These Companies

QTREX Interconnect Independently Tested at 20 mK by a Leading Quantum Computing Company; Over 100 dB Channel Isolation, 60 dB Beyond the Market Leader
October 1 at 8:45 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/10/01/3372917/0/en/qtrex-interconnect-independently-tested-at-20-mk-by-a-leading-quantum-computing-company-over-100-db-channel-isolation-60-db-beyond-the-market-leader.html
Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) Stock: Insider Dagi Shahar Ben-Noon Purchases 168,894 Shares
October 1 at 4:23 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31073139
Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) CEO Purchases $119,914.74 in Stock
September 30 at 4:37 AM  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-qtex-insider-buying-and-selling-2026-09-30/
QTREX Quantum Reports First Half 2026 Financial Results
September 24, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/24/3368310/0/en/qtrex-quantum-reports-first-half-2026-financial-results.html
Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) Stock Price Down 1.3% - Here's Why
September 24, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31043001
One of Israel's 3 Largest Defense Companies Begins Immediate Deployment of QTREX Quantum's AME Technology
September 2, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/02/3355146/0/en/one-of-israel-s-3-largest-defense-companies-begins-immediate-deployment-of-qtrex-quantum-s-ame-technology.html
Correction: QTREX Establishes Cryogenic Interconnect Capacity, More Than Four Times the Highest Publicly Disclosed Industry Benchmark
August 31, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/31/3353393/0/en/correction-qtrex-establishes-cryogenic-interconnect-capacity-more-than-four-times-the-highest-publicly-disclosed-industry-benchmark.html
QTREX to Unveil Ultra-High-Density Interconnect Architecture Supporting 17,280 Coaxial Lines per Cryogenic Stage at IEEE Quantum Week 2026
August 31, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/31/3353366/0/en/qtrex-to-unveil-ultra-high-density-interconnect-architecture-supporting-17-280-coaxial-lines-per-cryogenic-stage-at-ieee-quantum-week-2026.html
QTREX Announces Pricing of a $10 Million Registered Direct Offering of Ordinary Shares
August 20, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/20/3348346/0/en/qtrex-announces-pricing-of-a-10-million-registered-direct-offering-of-ordinary-shares.html
QTREX's Patent-Pending Technology Achieves First Direct Conversion of 3D-Printed Insulation into Graphene-Like Carbon to Protect Quantum Processors
August 19, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/19/3347716/0/en/qtrex-s-patent-pending-technology-achieves-first-direct-conversion-of-3d-printed-insulation-into-graphene-like-carbon-to-protect-quantum-processors.html
QTREX and U.S. Department of Defense Laboratory Target Q4 2026 to Formalize Joint Quantum Development Program
August 13, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/13/3344457/0/en/qtrex-and-u-s-department-of-defense-laboratory-target-q4-2026-to-formalize-joint-quantum-development-program.html
QTREX Proprietary Quantum Interconnect Platform Exceeds Performance Requirements Established by Strategic Partners
July 31, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/31/3336830/0/en/qtrex-proprietary-quantum-interconnect-platform-exceeds-performance-requirements-established-by-strategic-partners.html
QTREX Launches Quantum Interconnect Research Program with Commercialization Rights to Project-Generated IP
July 27, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/27/3333405/0/en/qtrex-launches-quantum-interconnect-research-program-with-commercialization-rights-to-project-generated-ip.html
QTREX Announces Clarification to Registration Statement on Form F-1
July 22, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/22/3331616/0/en/qtrex-announces-clarification-to-registration-statement-on-form-f-1.html
Inspira Technologies Oxy B.h.n.
July 21, 2026  |  fool.comhttps://www.fool.com/quote/nasdaq/iinn/
QTREX Appoints Dr. Shlomit Chappel-Ram, Veteran AME R&D Executive, as Independent Director
July 17, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/17/3329072/0/en/qtrex-appoints-dr-shlomit-chappel-ram-veteran-ame-r-d-executive-as-independent-director.html
QTREX Secures Commercial Order and Begins Production for Leading International Government-Owned Company
July 14, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/14/3326922/0/en/qtrex-secures-commercial-order-and-begins-production-for-leading-international-government-owned-company.html
QTREX Establishes U.S. Subsidiary to Advance Federal Government Contracting
July 10, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/10/3325437/0/en/qtrex-establishes-u-s-subsidiary-to-advance-federal-government-contracting.html
QTREX Announces Operational AME System at U.S. Government Lab with a Quantum Computing Program focused on National Security
July 6, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/06/3322397/0/en/qtrex-announces-operational-ame-system-at-u-s-government-lab-with-a-quantum-computing-program-focused-on-national-security.html
QTREX Engineers Conductivity Itself to Address Quantum Computing's Cryogenic Heat-Load Barrier
July 1, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/01/3320608/0/en/qtrex-engineers-conductivity-itself-to-address-quantum-computing-s-cryogenic-heat-load-barrier.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Hyperfine stock logo

Hyperfine NASDAQ:HYPR

$0.87 +0.06 (+7.88%)
Closing price 04:00 PM Eastern
Extended Trading
$0.88 +0.00 (+0.38%)
As of 07:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.

Pulmonx stock logo

Pulmonx NASDAQ:LUNG

$1.91 0.00 (0.00%)
Closing price 04:00 PM Eastern
Extended Trading
$1.90 0.00 (-0.26%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. It also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. The company serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.

NeurAxis stock logo

NeurAxis NASDAQ:NRXS

$7.17 -0.20 (-2.71%)
Closing price 04:00 PM Eastern
Extended Trading
$7.16 -0.01 (-0.21%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.

Inspira Technologies OXY B.H.N. stock logo

Inspira Technologies OXY B.H.N. NASDAQ:QTEX

$0.78 +0.10 (+15.04%)
Closing price 04:00 PM Eastern
Extended Trading
$0.84 +0.06 (+7.44%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra'annana, Israel.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas